Stay updated on Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Sign up to get notified when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.

Latest updates to the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page
- Check2 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedNo changes detected on the page; the content and layout appear unchanged.SummaryDifference0.1%

- Check31 days agoChange DetectedNo additions or deletions detected; the page content appears unchanged.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed. This update appears to reflect a metadata version bump without changing study data or user-facing content.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded Study Protocol and Statistical Analysis Plan PDFs, IPD sharing policy and URL, and updated to show 106 locations.SummaryDifference100%

Stay in the know with updates to Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.